Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Shares Issued (2020 - 2022)

Edesa Biotech's Shares Issued history spans 9 years, with the latest figure at $120.0 for Q3 2022.

  • For Q3 2022, Shares Issued rose 100.01% year-over-year to $120.0; the TTM value through Sep 2022 reached $12.0 million, up 28383.57%, while the annual FY2025 figure was $7.7 million, 958.1% up from the prior year.
  • Shares Issued for Q3 2022 was $120.0 at Edesa Biotech, down from $12.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $12.0 million in Q2 2022 and bottomed at -$1.4 million in Q3 2021.
  • The 5-year median for Shares Issued is $45000.0 (2019), against an average of $1.5 million.
  • The largest annual shift saw Shares Issued surged 2111.2% in 2020 before it tumbled 122.45% in 2021.
  • A 5-year view of Shares Issued shows it stood at -$130340.0 in 2018, then skyrocketed by 134.53% to $45000.0 in 2019, then soared by 2111.2% to $995038.0 in 2020, then rose by 29.36% to $1.3 million in 2021, then tumbled by 99.99% to $120.0 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Shares Issued are $120.0 (Q3 2022), $12.0 million (Q2 2022), and -$1.3 million (Q1 2022).